MorphoSys AG — Regulatory Filings 2001

Nov 28, 2001

News Details

Ad-hoc | 28 November 2001 07:31

MorphoSys AG english

MorphoSys Unveils New Antibody Library Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– MorphoSys Unveils New Antibody Library HuCAL GOLD Sets New Standard in Antibody Technology MorphoSys AG (Neuer Markt: MOR) today announced the development and release of a new proprietary antibody library, HuCAL GOLD. The library is to be presented at the 12th IBC Antibody Engineering conference in San Diego, California. Initial results show that the new library and related screening system lead to faster and more efficient antibody generation, as well as enabling the achievement of higher average affinity antibodies and more diverse fully human antibodies. Furthermore, the new library increases the Companys independence from several on-going patent disputes. HuCAL GOLD contains several significant innovations over previous versions of the HuCAL library and is combined with the Companys proprietary CysDisplay screening technology. Importantly, the new library possesses diverse repertoires in all six CDR regions of the underlying antibody genes, meaning that HuCAL GOLD provides more diversity than previous versions. Moreover in combination with the CysDisplay screening technology it is expected that the recovery of high affinity antibodies will be facilitated. The Company has granted patents and pending patent applications covering the antibody library technology and related screening methods and anticipates full freedom to practice. As such, the new library and screening system is intended to be a cornerstone of a future Company product development program. end of ad-hoc-announcement (c)DGAP 28.11.2001 ——————————————————————————– WKN: 663200; Index: Nemax 50 Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 280731 Nov 01